SIP
LFCR icon

Stoneridge Investment Partners’s Lifecore Biomedical LFCR Stock Holding History

Stoneridge Investment Partners’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-14,804
Closed -$175K – 306
2015
Q4 		$175K Sell
14,804
-1,642
-10% -$20.2K 0.02% 263
2015
Q3 		$192K Buy
+16,446
New +$218K 0.03% 260
2013
Q4 		– Sell
-20,934
Closed -$255K – 218
2013
Q3 		$255K Buy
20,934
+4,100
+24% +$57.2K 0.06% 162
2013
Q2 		$222K Buy
+16,834
New +$233K 0.05% 163

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Stoneridge Investment Partners's LFCR Position: Q1 2016 in Review

Stoneridge Investment Partners sold out of Lifecore Biomedical (LFCR) in Q1 2016, closing a stake of 14,804 shares — an estimated $175K sold.

Stoneridge Investment Partners first reported a position in LFCR in Q2 2013 and held it in 4 quarters. The position peaked at $255K in Q3 2013. 96 funds tracked by Wall St. Rank hold LFCR as of Q1 2016.

  • Stoneridge Investment Partners reported no remaining Lifecore Biomedical position as of Q1 2016 after selling out during the quarter.
  • Stoneridge Investment Partners sold 14,804 Lifecore Biomedical shares in Q1 2016, an estimated $175K.
  • Stoneridge Investment Partners first reported a position in Lifecore Biomedical in Q2 2013 and held it in 4 quarters.
  • Stoneridge Investment Partners's Lifecore Biomedical position peaked at $255K in Q3 2013.
  • 96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2016.

Based on Stoneridge Investment Partners's 13F filing for Q1 2016, filed 29 Apr 2016.